Research Atlas · source screening

Caspofungin

An attributable first-pass index of PubMed records whose titles name this governed identity. Records are sorted by publication date, not by evidence strength. Inclusion does not establish efficacy, safety, or a clinical indication.

Title-search results

1,181

Shown with stable PMIDs

25

Search recorded

2026-09-26

Source: NCBI PubMed / MEDLINE · exact query: "Caspofungin"[Title] · up to 25 recent title matches per identity. Each result links to its PubMed record.

1. Deletion of core septin gene aspB in Aspergillus fumigatus results in fungicidal activity of caspofungin.

   Mol Biol Cell · 2026 Sep 16 · PMID 42748000 · DOI 10.1091/mbc.E26-03-0151

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

2. Caspofungin pharmacokinetics in a child undergoing continuous veno-venous haemodiafiltration: a case report.

   Int J Antimicrob Agents · 2026 Sep 9 · PMID 42716406 · DOI 10.1016/j.ijantimicag.2026.108002

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

3. Endoplasmic reticulum stress reduces caspofungin resistance in Cryptococcus neoformans.

   mSphere · 2026 Sep 4 · PMID 42695676 · DOI 10.1128/msphere.00451-26

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

4. Calcineurin-Dependent Stress Adaptation Enables Caspofungin Heteroresistance Leading to Stable Resistance in Candida Glabrata.

   Adv Sci (Weinh) · 2026 Sep · PMID 42365577 · DOI 10.1002/advs.76369

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

5. Context-dependent immunomodulation by caspofungin: inflammatory attenuation involving spleen tyrosine kinase signaling in monocytic-cell systems versus pathogen-mediated immune amplification.

   Microlife · 2026 · PMID 42609701 · DOI 10.1093/femsml/uqag028

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

6. In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of Candida (Candidozyma) auris.

   J Fungi (Basel) · 2026 Jul 24 · PMID 42646079 · DOI 10.3390/jof12080552

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

7. Suspected Caspofungin-Induced Visual Toxicity Manifesting as Temporary Decreased Vision: A Case Report.

   Hosp Pharm · 2026 Jul 24 · PMID 42502731 · DOI 10.1177/00185787261470599

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

8. Efficacy of voriconazole combined with caspofungin in treating Chronic Obstructive Pulmonary Disease patients with invasive pulmonary aspergillosis: impacts on clinical outcomes, inflammatory cytokines, and immune markers.

   Front Immunol · 2026 · PMID 42553150 · DOI 10.3389/fimmu.2026.1831585

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

9. Correction: Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases.

   Front Pharmacol · 2026 · PMID 42524035 · DOI 10.3389/fphar.2026.1916009

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

10. Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 Trials.

    Mycoses · 2026 Jul · PMID 42460544 · DOI 10.1111/myc.70205

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

11. Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases.

    Front Pharmacol · 2026 · PMID 42394979 · DOI 10.3389/fphar.2026.1840717

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

12. Evaluation of Sensititre YeastOne for antifungal susceptibility testing of Candida (Candidozyma) auris: misclassification of FKS1 mutants and overestimation of caspofungin resistance in a global collection of isolates.

    J Clin Microbiol · 2026 Jun 10 · PMID 42132416 · DOI 10.1128/jcm.00130-26

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

13. Fpr1p mediates the synergistic effect of rapamycin or tacrolimus with caspofungin in Clavispora lusitaniae in vitro.

    JAC Antimicrob Resist · 2026 Jun · PMID 42179906 · DOI 10.1093/jacamr/dlag091

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

14. Structural basis of fungal β-1,3-glucan synthase inhibition by caspofungin.

    Nature · 2026 Jun · PMID 42020744 · DOI 10.1038/s41586-026-10409-7

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

15. Caspofungin-Based Red-Emissive Probes for Fluorescent Imaging of Pathogenic Fungi.

    JACS Au · 2026 May 25 · PMID 42212064 · DOI 10.1021/jacsau.6c00209

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

16. Ubiquinone-based gene mutation and protein compactness of CoQ5 may contribute to a novel caspofungin resistance mode in Aspergillus flavus from pulmonary aspergillosis.

    Diagn Microbiol Infect Dis · 2026 May · PMID 41690241 · DOI 10.1016/j.diagmicrobio.2026.117310

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

17. Adsorption of caspofungin by polyacrylonitrile membranes during continuous kidney replacement therapy.

    Intensive Care Med · 2026 May · PMID 41498941 · DOI 10.1007/s00134-025-08276-3

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

18. Repurposing caspofungin as a small-molecule inhibitor of Clostridium perfringens α-toxin for treatment of gas gangrene.

    Commun Med (Lond) · 2026 Apr 16 · PMID 41991712 · DOI 10.1038/s43856-026-01503-y

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

19. Synergistic activity of caspofungin and posaconazole against Candida (Candidozyma) auris biofilms based on phenotypic, transcriptomic, and in vivo insights.

    Microbiol Spectr · 2026 Apr 7 · PMID 41817193 · DOI 10.1128/spectrum.02686-25

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

20. Synergistic eradication of Candida albicans prosthetic valve endocarditis with liposomal amphotericin B and high-dose caspofungin: a case report.

    Front Med (Lausanne) · 2026 · PMID 41859156 · DOI 10.3389/fmed.2026.1704496

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

21. Comment on 'Retrospective analysis of pharmacological therapeutic monitoring of caspofungin in patients undergoing continuous renal replacement therapy using polyacrylonitrile membranes'.

    J Antimicrob Chemother · 2026 Mar 4 · PMID 41853962 · DOI 10.1093/jac/dkag094

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

22. Retrospective analysis of pharmacological therapeutic monitoring of caspofungin in patients undergoing continuous renal replacement therapy using polyacrylonitrile membranes-right to reply.

    J Antimicrob Chemother · 2026 Mar 4 · PMID 41810880 · DOI 10.1093/jac/dkag095

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

23. The siderophore transporter Sit1 is involved in the uptake of caspofungin by Candida albicans.

    Antimicrob Agents Chemother · 2026 Mar 4 · PMID 41609499 · DOI 10.1128/aac.01236-25

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

24. Corrigendum to "In vitro Susceptibilities to caspofungin of Candida spp. isolated from the Polyvalent Intensive Care Unit of Fattouma Bourguiba University Hospital: First report of resistant mutants in Tunisia" [J Mycol Med (2026) 101601].

    J Mycol Med · 2026 Mar · PMID 41637772 · DOI 10.1016/j.mycmed.2026.101606

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

25. Candidozyma auris: Identification, antifungal susceptibility, and caspofungin-induced paradoxical growth.

    Indian J Med Microbiol · 2026 Mar-Apr · PMID 41577033 · DOI 10.1016/j.ijmmb.2026.101065

    Source metadata only · evidence grade unassigned · scientific conclusions pending review